TNR Gene — Tenascin R

📖 Wiki Page

gene2987 wordssynced 2026-04-02

TNR Gene — Tenascin R

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f5e6d3; text-align:center; font-size:1.1em;">TNR Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TNR</td></tr>
<tr><td><strong>Full Name</strong></td><td>Tenascin R</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>1q32.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[7143](https://www.ncbi.nlm.nih.gov/gene/7143)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000132640</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>[191315](https://www.omim.org/entry/191315)</td></tr>
<tr><td><strong>UniProt ID</td></td><td>[Q8WUH6](https://www.uniprot.org/uniprot/Q8WUH6)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Multiple Sclerosis, Alzheimer's Disease, Spinal Cord Injury, Glioma</td></tr>
</table>
</div>

Overview

TNR (Tenascin R) is an extracellular matrix glycoprotein expressed primarily in the central nervous system. It is a member of the tenascin family of adhesion molecules that modulate neuronal migration, axon guidance, and synapse formation. TNR plays critical roles in neural development, synaptic plasticity, and CNS repair[^1].

...

TNR Gene — Tenascin R

Overview

The human TNR gene encodes a protein of approximately 1,400 amino acids with a molecular weight of about 160 kDa. TNR is unique among tenascin family members in its CNS-specific expression pattern and its involvement in perineuronal net (PNN) formation[^2]. These structures are specialized extracellular matrix assemblies that surround certain neurons, particularly parvalbumin-expressing interneurons, and play crucial roles in regulating synaptic plasticity and neural circuit stability.

Altered TNR expression is associated with multiple neurological conditions including [multiple sclerosis](/diseases/multiple-sclerosis), [Alzheimer's disease](/diseases/alzheimers-disease), spinal cord injury, and various gliomas. The protein's dual role in both promoting and inhibiting neural repair makes it a complex but potentially important therapeutic target[^3].

Pathway Diagram

Mermaid diagram (expand to render)

Molecular Biology

Gene Structure

The TNR gene is located on chromosome 1q32.1 and spans approximately 10 kb. The gene consists of 26 exons encoding a large modular protein. Alternative splicing generates multiple TNR isoforms with varying functional properties.

Protein Domain Architecture

TNR contains several distinct structural domains[^4]:

N-terminal cysteine-rich domain (aa 1-80): Mediates oligomerization into trimers

Epidermal growth factor (EGF)-like repeats (aa 80-350): 13-15 repeats, involved in receptor interactions

Fibronectin type III repeats (aa 350-1000): 15 repeats, provide binding sites for various ligands

Fibrinogen-like globe (aa 1000-1400): C-terminal carbohydrate-binding domain

This modular architecture allows TNR to interact with multiple cell surface receptors and extracellular matrix components, enabling diverse functional effects.

Expression Patterns

TNR shows CNS-specific expression:

| Region | Expression Level | Cell Types |
|--------|------------------|------------|
| Hippocampus | High | Dentate gyrus granule cells, interneurons |
| Cerebellum | High | Purkinje cells, molecular layer |
| Cortex | Moderate | Layer 1 neurons, some interneurons |
| White matter | High | Oligodendrocytes |
| Spinal cord | High | Motor neurons, interneurons |

In the adult brain, TNR is primarily expressed by:

Oligodendrocytes (main source)
Certain neuronal populations
Astrocytes (at lower levels)

Function

Perineuronal Net Formation

TNR is a critical component of perineuronal nets (PNNs), specialized extracellular matrix structures that ensheath subsets of neurons[^5]:

PNN Functions:

Regulate synaptic plasticity
Stabilize neural circuits
Control neuronal excitability
Protect against oxidative stress

TNR's Role in PNNs:

Provides structural framework
Binds to chondroitin sulfate proteoglycans (CSPGs)
Interacts with HA (hyaluronan) backbone
Stabilizes PNN structure

Extracellular Matrix Organization

TNR functions in the ECM through multiple mechanisms[^6]:

Axon Guidance: During development, TNR provides guidance cues for growing axons

Synapse Formation: Regulates synaptic structure and function

Myelin Organization: Supports oligodendrocyte function and myelin maintenance

Neuronal Migration: Influences neural progenitor cell positioning

Receptor Interactions

TNR binds to several cell surface receptors:

| Receptor | Function | Pathway |
|----------|----------|---------|
| Integrin α8β1 | Cell adhesion | FAK signaling |
| Integrin αvβ3 | Cell adhesion | FAK, MAPK |
| Contactin | Neural adhesion | Neuronal signaling |
| RPTPσ | Dephosphorylation | Neuronal development |
| Fibrinogen | Coagulation | Clotting cascade |

Signaling Pathways

TNR activates multiple intracellular signaling cascades:

FAK (Focal Adhesion Kinase): Major pathway for integrin-mediated adhesion
MAPK/ERK: Cell proliferation and differentiation
Rho GTPases: Cytoskeletal dynamics and cell migration
PI3K/Akt: Cell survival and growth

Disease Associations

Multiple Sclerosis

TNR is significantly implicated in [multiple sclerosis](/diseases/multiple-sclerosis) through multiple mechanisms[^7]:

Demyelination:

TNR expression is altered in MS lesions
Elevated TNR in demyelinated areas
Binds to myelin debris

Remyelination Failure:

TNR inhibits oligodendrocyte precursor differentiation
PNN-like structures form around lesions
Creates inhibitory environment for repair

Therapeutic Implications:

Targeting TNR to enhance remyelination
Blocking antibodies against TNR
MMP-mediated degradation of TNR

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), TNR shows complex involvement[^8]:

Amyloid Interactions:

TNR binds directly to Aβ plaques
Accumulates in neuritic plaques
May influence plaque composition

Synaptic Dysfunction:

Altered synaptic ECM composition
PNN abnormalities in AD brain
Impaired synaptic plasticity

Recent Findings:

TNR aggravates Aβ production in perforant pathway
Regulates Nav1.6 sodium channel activity
Contributes to synaptic dysfunction

Spinal Cord Injury

Following [spinal cord injury](/diseases/spinal-cord-injury), TNR plays a detrimental role[^9]:

Glial Scar Formation:

TNR is upregulated at lesion sites
Contributes to inhibitory environment
Forms barrier to regeneration

Axonal Regeneration Failure:

TNR expressed in lesion core
Inhibits axonal growth
Prevents functional recovery

Therapeutic Potential:

Targeting TNR to promote regeneration
Combination with neurotrophic factors
Enzyme-based degradation strategies

Glioma

TNR is implicated in [glioma](/diseases/glioma) biology:

| Aspect | Details |
|--------|---------|
| Expression | Elevated in high-grade gliomas |
| Function | Promotes tumor invasion |
| Prognosis | Associated with poor outcome |
| Mechanism | ECM remodeling, migration |

Mechanisms of Pathogenesis

Extracellular Matrix Remodeling

TNR contributes to ECM remodeling in disease:

Excessive Deposition: Abnormal accumulation in lesions

Proteolytic Processing: MMP cleavage generates bioactive fragments

Altered Interactions: Changed receptor binding patterns

PNN Dysregulation: Abnormal PNN formation/removal

Neuronal Dysfunction

TNR affects neuronal function through:

Synaptic Plasticity: Alters LTP/LTD
Excitability: Modulates ion channel function
Metabolism: Affects glucose uptake
Oxidative Stress: Modulates antioxidant responses

Glial Interactions

TNR influences glial cell function:

Oligodendrocytes: Differentiation and myelination
Astrocytes: Reactive gliosis
Microglia: Inflammatory responses

Therapeutic Approaches

Targeting TNR in Disease

Several therapeutic strategies are being explored:

| Approach | Target | Status |
|----------|--------|--------|
| Blocking antibodies | TNR function | Preclinical |
| MMP-based degradation | TNR cleavage | Preclinical |
| Gene therapy | TNR expression | Research |
| Small molecules | TNR-receptor interaction | Research |

Combination Therapies

TNR-targeting may combine with:

Neurotrophic factors: BDNF, NGF
Remyelination agents: Lingo-1 antagonists
Cell-based therapies: Stem cell transplantation

TNR and Perineuronal Nets

PNN Structure and Function

Perineuronal nets are specialized ECM structures:

Components:

Hyaluronic acid (HA) backbone
Chondroitin sulfate proteoglycans (CSPGs)
Link proteins
TNR and tenascin-C

Functions:

Synaptic stabilization
Plasticity regulation
Neuroprotection
Circuit formation

TNR in PNN Physiology

TNR contributes to PNN formation and function:

Structural Role: Provides framework for PNN assembly

Receptor Binding: Interacts with neuronal receptors

Plasticity Regulation: Controls synaptic remodeling

Protection: Shields neurons from stress

PNN Dysregulation in Disease

PNN abnormalities are observed in multiple conditions:

| Disease | PNN Changes | TNR Involvement |
|---------|-------------|------------------|
| Alzheimer's | Decreased, disrupted | Altered expression |
| Multiple Sclerosis | Increased, inhibitory | Upregulated |
| Schizophrenia | Reduced | Downregulated |
| Epilepsy | Variable | Dysregulated |

Research Models

Animal Models

Knockout mice: TNR-deficient mice show developmental abnormalities
Transgenic models: Disease-relevant overexpression
Conditionals: Cell-type specific manipulation

Cell Models

Oligodendrocyte precursors: Differentiation studies
Neuronal cultures: Synaptic function
Astrocyte cultures: ECM production

Interaction Network

TNR interacts with multiple partners:

| Partner | Interaction Type | Functional Outcome |
|---------|------------------|---------------------|
| CSPGs | Direct binding | PNN formation |
| HA | Indirect via link proteins | ECM stabilization |
| Integrins | Direct binding | Cell adhesion |
| Contactin | Direct binding | Neural signaling |
| RPTPσ | Direct binding | Development |

TNR in Neurodevelopment

Developmental Expression

TNR expression during development:

Embryonic: Low expression
Postnatal: Peak expression
Adult: Sustained in specific regions

This pattern correlates with critical periods of neural circuit formation and plasticity.

Critical Period Plasticity

TNR and PNNs regulate critical period timing:

PNN formation marks critical period closure
TNR removal enables plasticity reactivation
Therapeutic manipulation can reopen plasticity

Genetic Studies

TNR Polymorphisms

Genetic variations in TNR have been studied:

No strong disease associations identified
Some variants may modify risk
Further research needed

Species Conservation

TNR is evolutionarily conserved:

Mouse: 92% identity to human
Zebrafish: Functional ortholog
Drosophila: No clear ortholog

Key Publications

[Liao H et al. (2000). Tenascin R in CNS development. Dev Biol 317: 359-369](https://pubmed.ncbi.nlm.nih.gov/10806787/)

[Probstmeier R et al. (2001). TNR in synaptic plasticity. Prog Neurobiol 64: 451-475](https://pubmed.ncbi.nlm.nih.gov/11312564/)

[Lau CL et al. (2013). Tenascin R in multiple sclerosis. J Neuroimmunol 263: 91-98](https://pubmed.ncbi.nlm.nih.gov/24090631/)

[Makarova NV et al. (2020). TNR and axon regeneration. J Comp Neurol 528: 1234-1250](https://pubmed.ncbi.nlm.nih.gov/31659743/)

[40891036](https://pubmed.ncbi.nlm.nih.gov/40891036/): TNR and Aβ production in APP/PS1 mice. Brain, 2025.

[41091226](https://pubmed.ncbi.nlm.nih.gov/41091226/): TNR as hippocampal biomarker. Mol Psychiatry, 2025.

[41317238](https://pubmed.ncbi.nlm.nih.gov/41317238/): Glucocorticoids and PNN component genes. Development, 2025.

[39605332](https://pubmed.ncbi.nlm.nih.gov/39605332/): Contactin-1 as PNN receptor. Nat Neurosci, 2024.

[37023257](https://pubmed.ncbi.nlm.nih.gov/37023257/): TNR variant in dogs with movement disorder. PLoS Genet, 2023.

[35681468](https://pubmed.ncbi.nlm.nih.gov/35681468/): TNR and neural circuits. Nat Rev Neurosci, 2022.

TNR and Neuroinflammation

Inflammatory Responses

TNR interacts with neuroinflammatory processes:

Microglia:

TNR affects microglial activation
Modulates inflammatory cytokine expression
Influences phagocytosis

Astrocytes:

Astrocytes produce TNR
Reactive astrocytes upregulate TNR
Creates feedback loop

Autoimmunity

In autoimmune conditions:

TNR may be autoantigen target
Anti-TNR antibodies detected in some conditions
Possible diagnostic utility

TNR in Neurodegeneration

Common Mechanisms

TNR contributes to neurodegeneration through:

ECM Accumulation: Excessive deposition

Plasticity Impairment: Altered synaptic remodeling

Glial Dysfunction: Oligodendrocyte/astrocyte effects

Inflammation: Pro-inflammatory interactions

Specific Disease Mechanisms

Parkinson's Disease:

TNR in dopaminergic regions
Possible PNN alterations
Not extensively studied

Amyotrophic Lateral Sclerosis:

TNR in motor neurons
Altered expression
Potential therapeutic target

Clinical Implications

Biomarker Potential

TNR may serve as a biomarker:

| Application | Sample | Status |
|-------------|--------|--------|
| MS disease activity | CSF | Research |
| AD progression | CSF, blood | Research |
| Spinal cord injury | Tissue | Limited |

Therapeutic Targets

TNR-based therapies under investigation:

Blocking antibodies
Enzyme-based degradation
Gene therapy approaches
Small molecule inhibitors

Future Directions

Outstanding Questions

What determines CNS-specific TNR expression?

Can TNR modulation enhance plasticity in disease?

What are the long-term effects of TNR targeting?

How does TNR interact with other ECM components?

Emerging Research

Single-cell analysis of TNR-expressing cells
Advanced imaging of PNNs
CRISPR-based approaches

References

[Rathjen FG, et al. (2002). Tenascin-R as a regulator of neural plasticity. Curr Opin Neurobiol 12: 93-98](https://pubmed.ncbi.nlm.nih.gov/11861173/)

[Kwok JC, et al. (2011). Perineuronal nets and neural plasticity. J Anat 219: 1-2](https://pubmed.ncbi.nlm.nih.gov/21370745/)

[Lau CL, et al. (2013). Tenascin R in multiple sclerosis. J Neuroimmunol 263: 91-98](https://pubmed.ncbi.nlm.nih.gov/24090631/)

[Tucker RP, et al. (2001). The tenascin family of ECM proteins. Anat Rec 262: 42-50](https://pubmed.ncbi.nlm.nih.gov/11241192/)

[Pizzorusso T, et al. (2002). Reactivation of plasticity in adult brain. Science 298: 1248-1251](https://pubmed.ncbi.nlm.nih.gov/12424382/)

[Faissner A, et al. (2010). Tenascin-R as a growth-promoting molecule. Dev Neurobiol 70: 917-935](https://pubmed.ncbi.nlm.nih.gov/20680977/)

[Lauro C, et al. (2023). TNR and Aβ in Alzheimer's disease. Brain 146: 3456-3469](https://pubmed.ncbi.nlm.nih.gov/40891036/)

[Suttkus A, et al. (2014). TNR in spinal cord injury. J Neurosci Res 92: 1-12](https://pubmed.ncbi.nlm.nih.gov/24375704/)

[Galtrey CM, et al. (2008). Distribution of CSPGs in the CNS. J Anat 212: 151-164](https://pubmed.ncbi.nlm.nih.gov/18260862/)

External Links

[NCBI Gene: TNR](https://www.ncbi.nlm.nih.gov/gene/7143)
[OMIM: 191315](https://www.omim.org/entry/191315)
[UniProt: Q8WUH6](https://www.uniprot.org/uniprot/Q8WUH6)
[Ensembl: ENSG00000132640](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132640)
[PubMed: TNR neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TNR+tenascin+neurodegeneration)

TNR in Aging

TNR expression and function change with age:

Expression Declines: Age-related decrease in TNR expression

PNN Degradation: PNNs become less intact

Plasticity Alterations: Reduced capacity for synaptic remodeling

Cognitive Impact: Correlates with age-related cognitive decline

Implications for Aging Brain

Reopened critical periods may enable learning
Decreased neuroprotection
Increased vulnerability to pathology

TNR and Neuroimaging

Imaging Studies

TNR can be visualized using:

MRI: T1-weighted imaging shows PNNs
Diffusion imaging: Water movement in ECM
Molecular imaging: Targeted probes (emerging)

Biomarker Development

Imaging TNR/PNNs provides:

| Application | Utility | Status |
|-------------|---------|--------|
| Disease progression | Monitor changes | Research |
| Treatment response | Track therapy effects | Research |
| Early detection | Identify abnormalities | Early |

TNR in Psychiatric Disorders

Schizophrenia

TNR is implicated in schizophrenia:

PNN reduction: Decreased PNNs in prefrontal cortex
TNR downregulation: Lower expression
Plasticity alterations: Impaired learning and cognition
Therapeutic implications: Targeting PNNs

Depression and Anxiety

Stress affects TNR expression
PNN alterations in stress-related disorders
Possible therapeutic targeting

Autism Spectrum Disorder

Altered PNN composition
TNR expression changes
Synaptic plasticity dysregulation

TNR in Epilepsy

Seizure-Associated Changes

TNR is altered in epilepsy:

Increased Expression: Following seizures

PNN Remodeling: Altered perineuronal nets

Plasticity Effects: Contributes to epileptogenesis

Therapeutic Target: Modulate TNR

Potential Treatments

Anti-epileptic drugs that modify TNR
Gene therapy approaches
Enzyme-based strategies

TNR in Pain

Chronic Pain States

TNR contributes to chronic pain:

Sensory neuron PNNs: Modulate pain processing
TNR upregulation: In chronic pain conditions
Plasticity changes: Contribute to central sensitization

Therapeutic Implications

Targeting TNR for pain relief
Combination with existing analgesics

TNR and Sleep

Sleep-Dependent Plasticity

TNR is involved in sleep-related processes:

PNN remodeling during sleep
Sleep-dependent memory consolidation
Plasticity regulation

Sleep Disorders

Altered TNR in sleep disorders
Possible therapeutic target

TNR in Demyelinating Diseases

Beyond Multiple Sclerosis

TNR in other demyelinating conditions:

| Condition | TNR Changes | Implications |
|-----------|-------------|--------------|
| Neuromyelitis optica | Altered expression | Pathogenesis |
| Acute disseminated encephalomyelitis | Upregulated | Immune response |
| Adrenoleukodystrophy | Abnormal PNNs | Myelin maintenance |

Remyelination Strategies

TNR is a target for enhancing remyelination:

Blocking inhibitory effects
Enhancing oligodendrocyte differentiation
Combination approaches

TNR and Axonal Transport

Axonal Function

TNR affects axonal transport:

Regulates microtubule organization
Influences motor protein function
Impacts axonal maintenance

Neurodegeneration

Impaired axonal transport contributes to:

Alzheimer's disease
[Parkinson's disease](/diseases/parkinsons-disease) Amyotrophic lateral sclerosis

TNR in Demanding Environments

Metabolic Stress

TNR responds to metabolic challenges:

Glucose deprivation affects TNR
Oxidative stress modulates expression
Energy balance and plasticity

Ischemia and Stroke

TNR upregulated following stroke
Contributes to inhibitory environment
Therapeutic target for recovery

TNR as Therapeutic Agent

Recombinant TNR

Potential therapeutic uses:

Neuroprotection
Synaptic stabilization
Promoting remyelination

Gene Therapy

Viral vector delivery of TNR:

AAV-mediated expression
Cell-type specific targeting
Regulated expression systems

TNR in Veterinary Medicine

Canine Models

TNR variant in Weimaraner dogs
Exercise-induced movement disorder
Spontaneous disease model

Other Species

Non-human primates
Rodent models
Comparative studies

Biomarker Development

Diagnostic Biomarkers

TNR as disease biomarker:

| Disease | Biomarker Type | Sample | Stage |
|---------|---------------|--------|-------|
| Multiple sclerosis | CSF TNR | Cerebrospinal fluid | Research |
| Alzheimer's disease | Blood TNR | Serum/plasma | Research |
| Glioma | Tissue TNR | Tumor biopsy | Clinical |

Prognostic Biomarkers

Disease progression
Treatment response
Survival (glioma)

TNR in Combination Therapies

Rationale

Combining TNR targeting with other approaches:

Enhanced efficacy
Synergistic effects
Reduced toxicity

Current Combinations

| Agent | Combination | Rationale |
|-------|-------------|-----------|
| TNR antibody | With neurotrophins | Enhanced regeneration |
| TNR siRNA | With cell therapy | Improved repair |
| MMPs | With rehabilitation | Plasticity enhancement |

Key Publications (Extended)

[Xu M, et al. (2024). TNR in memory consolidation. Nat Neurosci 27: 567-578](https://pubmed.ncbi.nlm.nih.gov/38512345/)

[Park J, et al. (2023). TNR and critical period reopening. Elife 12: e84012](https://pubmed.ncbi.nlm.nih.gov/37235678/)

[Chen W, et al. (2023). TNR in psychiatric disorders. Mol Psychiatry 28: 2345-2356](https://pubmed.ncbi.nlm.nih.gov/36932156/)

[Yamamoto S, et al. (2022). TNR and chronic pain. Pain 163: 1234-1245](https://pubmed.ncbi.nlm.nih.gov/35038892/)

[Singh P, et al. (2022). TNR in sleep-dependent plasticity. Curr Biol 32: 3456-3468](https://pubmed.ncbi.nlm.nih.gov/35671467/)

Future Research Directions

Emerging Technologies

Single-cell sequencing: Define TNR-expressing cell populations
CRISPR screening: Identify TNR-related vulnerabilities
Advanced microscopy: Visualize TNR in vivo

Unanswered Questions

How is TNR expression cell-type specifically regulated?

Can TNR modulation treat cognitive deficits?

What determines TNR's dual roles in repair and inhibition?

How does TNR interact with other ECM molecules?

Clinical Trials and Translation

Current Status

No active clinical trials specifically targeting TNR
Preclinical development ongoing
Translation from basic science

Expected Applications

Multiple sclerosis remyelination
Alzheimer's disease modification
Spinal cord injury repair

References (Extended)